Cigna modified MM 0453 for inhaled nitric oxide (INO), effective September 26, 2025. Here's what billing teams need to act on before that date.
Cigna Healthcare updated its coverage policy for inhaled nitric oxide under policy code MM 0453 in its coverage position criteria framework. This modification affects claims billed with CPT codes 93463, 94002, and 94003, and ties coverage to specific ICD-10 procedure codes for INO administration via the respiratory tract. If your facility bills for INO therapy or vasoreactivity testing, review your charge capture and documentation workflows now.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | Cigna Healthcare |
| Policy | Inhaled Nitric Oxide (INO) — Coverage Position Criteria |
| Policy Code | MM 0453 |
| Change Type | Modified |
| Effective Date | September 26, 2025 |
| Impact Level | High |
| Specialties Affected | Pulmonology, Critical Care, Neonatology, Cardiology, Cardiac Catheterization Labs |
| Key Action | Confirm CPT 93463, 94002, and 94003 claims pair with documented medical necessity for pulmonary vasoconstriction or vasoreactivity testing before September 26, 2025 |
Cigna Inhaled Nitric Oxide Coverage Criteria and Medical Necessity Requirements 2025
The Cigna inhaled nitric oxide coverage policy under MM 0453 covers INO therapy when it is used to treat conditions associated with reversible pulmonary vasoconstriction and pulmonary hypertension. It also covers INO for vasoreactivity testing. These are the two lanes where medical necessity is established under this policy.
The word "reversible" is doing a lot of work here. If pulmonary vasoconstriction is not reversible — or if documentation doesn't explicitly support that characterization — you're exposed to a claim denial. Your clinical documentation needs to make that case before the claim goes out the door.
CPT 93463 covers pharmacologic agent administration in the cardiac catheterization lab setting, specifically including inhaled nitric oxide as an example agent. This code gets used during vasoreactivity testing, which is a key covered indication under MM 0453. CPT 94002 and 94003 cover ventilation assist and management — initiation of pressure or volume preset ventilators for assisted or controlled breathing. These codes apply when INO delivery runs alongside mechanical ventilation, which is the typical scenario in critical care and neonatal settings.
All three CPT codes carry a "Considered Medically Necessary when used in association with" designation in the policy. That phrase means the codes aren't freestanding approvals. Coverage depends on the clinical context meeting the stated criteria. Document the indication clearly. If you're billing for INO during vasoreactivity testing, make sure 93463 is paired with the appropriate diagnosis. If you're billing 94002 or 94003 for INO delivery during mechanical ventilation, the record needs to show pulmonary hypertension or reversible pulmonary vasoconstriction as the driving condition.
Cigna's coverage policy does not explicitly list prior authorization requirements in the published MM 0453 language. That said, INO therapy is a high-cost intervention. Given that context, prior authorization requirements may apply at the plan level. Verify with the individual plan before initiating treatment whenever possible. Don't assume the absence of a published PA requirement means no PA is needed.
Reimbursement for INO claims hinges on matching the right CPT code to the right clinical context. Billing 94002 versus 94003 is not interchangeable — 94002 is for hospital inpatient, 94003 is for nursing facility/home setting. Know which venue applies to your claim.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Reversible pulmonary vasoconstriction treatment | Covered | CPT 94002, 94003; ICD-10 3E0F7SD, 3E0F8SD | Medical necessity documentation must support "reversible" characterization |
| Pulmonary hypertension treatment with INO | Covered | CPT 94002, 94003; ICD-10 3E0F7SD, 3E0F8SD | Pair with appropriate pulmonary hypertension diagnosis code |
| Vasoreactivity testing (pharmacologic agent administration) | Covered | CPT 93463; ICD-10 3E0F3SD | Typically performed in cardiac cath lab; documentation must reflect INO as the pharmacologic agent used |
| INO via percutaneous approach | Covered (when criteria met) | ICD-10 3E0F3SD | Less common delivery route; same medical necessity criteria apply |
| INO via natural or artificial opening | Covered (when criteria met) | ICD-10 3E0F7SD | Most common route in ventilated patients |
| INO via natural or artificial opening, endoscopic | Covered (when criteria met) | ICD-10 3E0F8SD | Confirm route matches clinical record and billing documentation |
Cigna Inhaled Nitric Oxide Billing Guidelines and Action Items 2025
These are the steps your billing team needs to take before the effective date of September 26, 2025.
| # | Action Item |
|---|---|
| 1 | Audit your charge capture for CPT 93463, 94002, and 94003. Pull claims from the last 90 days. Confirm each one has a documented indication that maps to reversible pulmonary vasoconstriction, pulmonary hypertension, or vasoreactivity testing. Any claim that can't make that connection is a denial risk under the updated policy. |
| 2 | Train clinical staff on documentation requirements. The "reversible" qualifier for pulmonary vasoconstriction is a documentation trap. Providers need to use that language explicitly in the record — not just note that pulmonary pressures were elevated. Work with your medical director or attending physicians to build that language into INO order sets and procedure notes before September 26, 2025. |
| 3 | Verify the correct ICD-10 procedure codes for the delivery route. Use 3E0F3SD for percutaneous approach, 3E0F7SD for natural or artificial opening, and 3E0F8SD for natural or artificial opening endoscopic. Mismatching the delivery route in the procedure code is a technical denial that's entirely avoidable. Confirm the route in the operative or procedure note before coding. |
| 4 | Distinguish 94002 from 94003 by care setting. Billing 94002 in the wrong setting — or billing 94003 for an inpatient encounter — creates a mismatch that triggers edits. Confirm your charge description master (CDM) routes these codes correctly based on the patient's location. |
| 5 | Check for plan-level prior authorization requirements. MM 0453 in its published form doesn't mandate PA, but individual Cigna plan contracts may. INO therapy is expensive enough that payers have financial incentive to require PA even when the coverage policy doesn't spell it out. Call the plan or run an eligibility check that includes benefit-level PA requirements before treatment when the clinical timeline allows. |
| 6 | Review denials for INO claims going back to early 2025. If Cigna updated MM 0453 on September 26, 2025, there may have been a draft or interim version guiding prior denials. Pull any INO-related denials from Q1 and Q2 2025 and check whether updated criteria might support an appeal. |
| 7 | Loop in your compliance officer if INO billing is high-volume at your facility. The intersection of high-cost therapy, a narrow covered indication, and a policy modification is exactly the combination that generates audit activity. If your facility bills INO regularly — especially in a NICU or cardiac cath lab — your compliance officer should review this policy update before the effective date. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Inhaled Nitric Oxide Under MM 0453
Covered CPT Codes (When Medical Necessity Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 93463 | CPT | Pharmacologic agent administration (e.g., inhaled nitric oxide, intravenous infusion of nitroprusside) — considered medically necessary when used in association with covered criteria |
| 94002 | CPT | Ventilation assist and management, initiation of pressure or volume preset ventilators for assisted or controlled breathing — hospital inpatient — considered medically necessary when used in association with covered criteria |
| 94003 | CPT | Ventilation assist and management, initiation of pressure or volume preset ventilators for assisted or controlled breathing — nursing facility or home — considered medically necessary when used in association with covered criteria |
Key ICD-10 Procedure Codes for Inhaled Nitric Oxide Administration
| Code | Description |
|---|---|
| 3E0F3SD | Introduction of Nitric Oxide Gas into Respiratory Tract, Percutaneous Approach |
| 3E0F7SD | Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening |
| 3E0F8SD | Introduction of Nitric Oxide Gas into Respiratory Tract, Via Natural or Artificial Opening Endoscopic |
Note: these are ICD-10-PCS procedure codes, not ICD-10-CM diagnosis codes. They describe the method of INO delivery. Your inpatient coders need to select the correct code based on how INO was physically administered, not just that it was used. On the outpatient side, verify whether your facility uses these codes or relies solely on the CPT codes — the application depends on your billing environment.
Get the Full Picture for CPT 93463
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.